Inhibition of NPC1 suppresses cell proliferation and β-catenin signaling activation of liver cancer
Journal of Cancer Research and Clinical Oncology · 2024
DOI: 10.1007/s00432-024-06023-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cancer Research and Clinical Oncology, 2024. Verfasst von Dan Cao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, 610041, China. Hauptthemen laut MEDLINE: Liver Neoplasms, Cell Proliferation, beta Catenin, Intracellular Signaling Peptides and Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the National Key Research and Development Program of China, 1.3.5 project for disciplines of excellence at West China Hospital, Sichuan University.
Abstract (Originalsprache)
Niemann-Pick Type C1 (NPC1) plays a significant role in the development of liver diseases and liver cancer. Our objective was to investigate the involvement of NPC1 in regulating liver cancer development. We observed that high levels of NPC1 expression in tumor tissues from patients with liver cancer were associated with a poor prognosis. Through in vitro experiments, we found that inhibiting NPC1 expression reduced the proliferation, invasion, and migration of liver cancer cells, while also inducing apoptosis in these cells. Additionally, the inhibition of NPC1 led to decreased activation of Wnt/β-catenin signaling. In vivo studies further supported our findings by demonstrating that the suppression of liver cancer cell growth was effectively achieved through the inhibition of NPC1. Overall, our results strongly indicate that the inhibition of NPC1 suppresses liver cancer cell proliferation. Targeting NPC1 is a promising potential therapeutic strategy for liver cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, 610041, China.
- Laboratory of Infectious and Liver Diseases, Institute of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, 610041, China.
- Department of Respiratory and Critical Care Medicine, Affiliated Hospital of North Sichuan Medical College, Nanchong, 637000, China.
- Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, 610041, China. tanghong6198@wchscu.cn.
- Laboratory of Infectious and Liver Diseases, Institute of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, 610041, China. tanghong6198@wchscu.cn.
Förderung
- the National Key Research and Development Program of China
- 1.3.5 project for disciplines of excellence at West China Hospital, Sichuan University
Zitieren
APA
Cao, D., Chen, H., He, M., Han, N., & Tang, H. (2024). Inhibition of NPC1 suppresses cell proliferation and β-catenin signaling activation of liver cancer. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-024-06023-7
Vancouver
Cao D, Chen H, He M, Han N, Tang H. Inhibition of NPC1 suppresses cell proliferation and β-catenin signaling activation of liver cancer. Journal of Cancer Research and Clinical Oncology. 2024. doi:10.1007/s00432-024-06023-7
BibTeX
@article{Cao2024,
author = {Cao, Dan and Chen, Han and He, Min and Han, Ning and Tang, Hong},
title = {Inhibition of NPC1 suppresses cell proliferation and β-catenin signaling activation of liver cancer},
journal = {Journal of Cancer Research and Clinical Oncology},
year = {2024},
doi = {10.1007/s00432-024-06023-7}
}
EUVIMED